Business Description
Metis TechBio Co Ltd
ISIN : CNE100007LD1
Share Class Description:
FRA:RO9: Class HCompare
Compare
Traded in other countries / regions
07666.Hong KongRO9.Germany IPO Date
2026-05-18Description
Metis TechBio Co Ltd is an investment holding company. The company and its subsidiaries are principally engaged in AI-empowered nanomaterial innovation for the delivery and application of active agents across all carbon-based life forms. Its technology platform, NanoForge, comprises a set of integrated tools, including a lipid library, AI models, an AI agent (METiS), quantum chemistry and molecular dynamics simulations, and high-throughput screening platforms. The company has developed three solution platforms (AiTEM, AiLNP, and AiRNA) designed to simulate, predict, and interpret nanoscale interactions, enabling the rational design, optimization, and validation of nanomaterials and their associated payloads.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 8.58 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -0.97 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 365.7 | |||||
3-Year EBITDA Growth Rate | 14.1 | |||||
3-Year EPS without NRI Growth Rate | 10.3 | |||||
3-Year FCF Growth Rate | 10.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.67 | |||||
Quick Ratio | 6.67 | |||||
Cash Ratio | 6.54 | |||||
Days Sales Outstanding | 3078.08 | |||||
Days Payable | 2497.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.84 | |||||
Operating Margin % | -4232.52 | |||||
Net Margin % | -4320.38 | |||||
EBITDA Margin % | -4016.02 | |||||
FCF Margin % | -2393.38 | |||||
OCF Margin % | -2362.5 | |||||
ROE % | -54.39 | |||||
ROA % | -11.98 | |||||
ROIC % | -51.64 | |||||
ROC (Joel Greenblatt) % | -179.29 | |||||
ROCE % | -13.54 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4080 | |||||
PB Ratio | 12.26 | |||||
Price-to-Tangible-Book | 12.84 | |||||
EV-to-EBIT | -81.89 | |||||
EV-to-EBITDA | -87.35 | |||||
EV-to-Revenue | 3507.91 | |||||
EV-to-FCF | -163.95 | |||||
| Price-to-Net-Current-Asset-Value | 14.27 | |||||
| Price-to-Net-Cash | 14.27 | |||||
Earnings Yield (Greenblatt) % | -1.22 | |||||
FCF Yield % | -0.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Metis TechBio Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.408 | ||
| EPS (TTM) (€) | -0.015 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 51.23 | ||
| 14-Day ATR (€) | 0.068898 | ||
| 20-Day SMA (€) | 1.16735 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 1.04 - 2.538 | ||
| Shares Outstanding (Mil) | 1,182.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Metis TechBio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Metis TechBio Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Metis TechBio Co Ltd Frequently Asked Questions
What is Metis TechBio Co Ltd(FRA:RO9)'s stock price today?
The current price of FRA:RO9 is €1.28. The 52 week high of FRA:RO9 is €2.54 and 52 week low is €1.04.
When is next earnings date of Metis TechBio Co Ltd(FRA:RO9)?
The next earnings date of Metis TechBio Co Ltd(FRA:RO9) is .
Does Metis TechBio Co Ltd(FRA:RO9) pay dividends? If so, how much?
Metis TechBio Co Ltd(FRA:RO9) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Metis TechBio Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers